Yahoo Finance's Oscar Williams-Grut has the latest from London.
Yahoo Finance's Oscar Williams-Grut has the latest from London.
Anita Anand, Minister of Public Services and Procurement, announced that Pfizer will be temporarily reducing deliveries of its COVID-19 vaccine to Canada.
City heavyweights said the ruling was a “validation” of the FCA and law firms’ hard work on behalf of small businesses
Aspocomp Group Plc, Inside Information, January 15, 2021 at 5:15 p.m. This release replaces the stock exchange release that Aspocomp Group Plc published today, January 15, at 11:30 a.m. EET. A typing error in the first paragraph of the English-language release has been corrected. The earlier version incorrectly referred to a “loan provision.” This has now been corrected to “credit loss provision.” Aspocomp’s January-December 2020 net sales is estimated to be EUR 25.6 million. Demand in the telecommunications networks and automotive segments in the fourth quarter was lower than expected. Due to the low net sales and the EUR 0.3 million credit loss provision recorded in the first quarter, Aspocomp’s operating result for January-December 2020 is estimated to be lower than previously forecast and to be approximately EUR -0.1 million. In its previous outlook for 2020 (the Interim Report on November 4, 2020) Aspocomp estimated that its net sales and operating result for 2020 will fall significantly short of the 2019 level. In 2019, net sales amounted to EUR 31.2 million and the operating result to EUR 3.4 million. Aspocomp's Financial Statements release January 1- December 31, 2020 will be released on Wednesday, March 10, 2021 at around 09:00 a.m. (EET). In conjunction with the publication of Aspocomp’s Financial Statements release 2020, Aspocomp will provide an outlook for 2021. For further information, please contact Mikko Montonen, President and CEO, tel. +358 40 5011 262, mikko.montonen(at)aspocomp.com. ASPOCOMP GROUP PLC Mikko Montonen President and CEO Aspocomp – heart of your technology A printed circuit board (PCB) is used for electrical interconnection and as a component assembly platform in electronic devices. Aspocomp provides PCB technology design, testing and logistics services over the entire lifecycle of a product. The company’s own production and extensive international partner network guarantee cost-effectiveness and reliable deliveries. Aspocomp’s customers are companies that design and manufacture telecommunication systems and equipment, automotive and industrial electronics, and systems for testing semiconductor components for security technology. The company has customers around the world and most of its net sales are generated by exports. Aspocomp is headquartered in Espoo and its plant is in Oulu, one of Finland’s major technology hubs. www.aspocomp.com
Property investors flocked to buy West End offices at the end of the year as hopes surrounding Covid vaccines improved, with over £1 billion of sales agreed in December, data shows. Although recent figures showed overall spend on central London offices, stores and office and retail development sites, tumbled in 2020, Savills showed the West End office investment market ended on a positive note. The property agent today said West End office transactions in the last three months of 2020 reached £2.9 billion, which is 38% above the five year average for final quarters.
Impeached president was removed from Twitter and Facebook after the Capitol Hill riots
David Moyes will have to make a call over whether to bring Lukasz Fabianski back into the fold after injury, but the West Ham goalkeeper is pushing to start once again. Said Benrahma struggled, along with most of his teammates, in the FA Cup win at Stockport on Monday but impressed with his work off the ball during the win at Goodison Park and should keep his place, with Michail Antonio coming in. It is thought youngster Mipo Odubeko, who is highly rated and made his first senior appearance in the dying minutes at Stockport, could be given a chance from the bench.
The "Drilling Fluids - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Which is best for sizzling good value? We put a range to the test
While, in person, wine shops can feel a little intimidating to head into – “What are you looking for?” feeling like a test of character, rather than an offer of help – the necessity of lockdown offers a little time to get to know your local specialist from the safety of your sofa. Take advantage of the time to get to know what you like; mixed cases often make a great introduction into a variety of styles, but most of London’s top wine-sellers are also an affable lot, ready to answer questions and offer recommendations.
David Chambers, 33, allegedly turned up on the pensioner’s doorstep offering to vaccinate her against coronavirus in exchange for payment. Prosecutor Matt Barrowcliffe said the pensioner lives alone in her Surbiton home.
The Europe kidney stones retrieval devices market is expected to reach US$ 1,020. 5 million by 2027 from US$ 724. 3million in 2019; it is estimated to grow with a CAGR of 4. 5% from 2020-2027. The growth of this market is attributed to the increasing prevalence of kidney stone disease and rise in the elderly population across Europe.New York, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Kidney Stones Retrieval Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type ; Treatment ; End User ; and Country" - https://www.reportlinker.com/p06004164/?utm_source=GNW However, the lack of awareness regarding renal stones hinders the market growth.Kidney stone devices include a wide range of stone retrieval tools such as lithotripter, stone baskets, ureteral stents, ureterorenoscopes, guidewires, and access sheath.These tools are tube-like structure that is attached with a camera to visualize the position of stones inside the ureter, and tools such as lithotripter are used to break down stones into pieces, and stone basket helps hold the stones pieces together.Accessories such as guidewires and access sheaths allow the insertion of stone removal devices into the ureter.The incidence of kidney stone disease is high among both the genders.It has a prevalence rate of ~7% among adults.The disease may reoccur after 10 years in many people. According to the European Union, the prevalence of CKD was 15.1% in 2018. The CKD cases are more common among men with age 40 and above. Also, there is a significant rise in the incidence of other chronic kidney diseases. For instance, according to t the National Health Examination Survey, in Italy, the prevalence rates of CKD are 7.5% among males and 6.5% among females of the age 35-79. Therefore, CKD includes various disorders and represents an actual significant public health burden in the country. Hence, in 2017, the Italian Ministry of Health promoted the institution of the national chronic kidney diseases registry to describe epidemiology in the country, monitor the quality of care and health outcomes, and prevent the incidence of the most severe and costly phases of this disease. The critical factor leading to the increasing incidence of kidney stones is dietary habits of people in different countries. In addition, factors such as obesity; dehydration; digestive disorders; medical conditions, including renal tubular acidosis, cystinuria, hyperparathyroidism, and repeated urinary tract infections; and medication consumption increase the risk of kidney stones among people.Thus, the increasing prevalence of kidney stone diseases is raising demand for kidney stone retrieval devices.The European economy is severely affected due to the exponential growth of COVID-19 cases in the region.Spain, Italy, Germany, France, and the UK are among the most affected European countries.As per the Worldometer, the UK, Spain, Italy, Germany, and France recorded 358,138; 554,143; 283,180; 258,107; and 353,944 cases, respectively, and the deaths toll is also high in these countries.Regulatory bodies in the region take preventive measures such as complete quarantine and shutting down all business operations.In March 2020, the European Medicines Agency established a managing committee to deal with the impact of COVID-19 on the supply chain of medicines and devices.Furthermore, once the COVID-19 pandemic subsides, hospitals and other healthcare providers are likely to experience constraints in their capacities and financial resources of perform noninvasive and minimally invasive procedures, which could harm demand for intracorporeal ureteroscopy.Many hospitals in Europe have also implemented vendor access restrictions, potentially limiting the ability of medical industry players to provide products and case support. Due to the fear of infection in patients and doctors, people are refraining from hospitals and avoiding surgical operations. These measures are hampering the overall manufacturing and marketing of kidney stone retrieval devices.Based on type,the kidney stones retrieval devices market is segmented intolithotripters, stone removal devices, ureteral stents, and ureterorenoscopes. The lithotripters segment held the largest share of the market in 2019; the same segment is further anticipated to register the highest CAGR in the market during the forecast period.Based on treatment, the kidney stones retrieval devices market is segmented into extracorporeal shock wave lithotripsy, intracorporeal ureteroscopy, and percutaneous nephrolithotripsy. The extracorporeal shock wave lithotripsy segment held the largest share of the market in 2019, and it is also expected to register the highest CAGR in the market during the forecast period.Based on end user, the kidney stones retrieval devices market is segmented into hospitals and clinics, specialty clinics, and ambulatory surgery centers. The hospitals and clinics segment held the largest share of the market in 2019, and the market for the same is estimated to grow at the highest CAGR during the forecast period.A few of the primary and secondary sources referred to while preparing the report on the Europe kidney stones retrieval devices market are the European Association of Urology (EAU) and National Health Examination Survey (Italy).Read the full report: https://www.reportlinker.com/p06004164/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.
Medical director Erika Denton said Norfolk and Norwich University Hospital has three times as many Covid patients as at the height of the first wave.
Founded by entrepreneur Greg Wyler in 2014, OneWeb aims to provide high-speed broadband internet services globally using low earth orbit satellites, taking on a similar offering by Elon Musk's SpaceX. The funding would allow OneWeb to cover the costs for its network of 648 satellites, expected to be ready by the end of 2022. SoftBank Group, a former investor in OneWeb, had pulled the plug on funding earlier, forcing OneWeb to file for bankruptcy protection in March.
There are still only three officially recognised symptoms - fever, cough and change in taste or sense of smell
This year for Valentine’s Day, I especially want to send love to my friends and family since we haven’t been together as much as we would, like and Greetabl is one of my favorite ways to show love from afar.
European Union nations are receiving fewer-than-expected doses of coronavirus vaccines as U.S. pharmaceutical firm Pfizer slows shipments while Turkey, China and Indonesia race ahead with inoculations to stem surging worldwide infections. But even when inoculations start en masse, the effects are not expected for months or until most people within a population get the shot. The vaccine developed by Pfizer with German partner BioNTech started being delivered in the EU at the end of December.
For information and support call Mind on 0300 123 339
At-home health testing kit startup Everlywell has raised $75 million, following the close of the $175 million Series D it announced in December. The new funding comes from HealthQuest Capital, and sees the fund's founder and managing partners Dr. Garheng Kong join the company's board of directors. HealthQuest Capital's investment portfolio has a heavy focus on commercialization of diagnostics businesses, and the company's parent obviously has a board network of partners including hospitals, and healthcare payers, both of which are going to be very strategically useful to Everlywell as it looks to scale its business on the enterprise side.
Stocks dipped as traders considered details of President-elect Joe Biden’s newly unveiled stimulus proposal and weighed the likelihood of the package getting advanced quickly through Congress.